Further twists in heparin scandal
A member of the US Congress has called on the GAO to launch an investigation into the FDA’s handling of the heparin crisis, citing “unanswered questions concerning [the] deaths”.
Archives for November 26, 2008
Hectic week of M&A led by the return of King to Alpharma
King Pharmaceuticals’ $1.6bn (€1.2bn) acquisition of Alpharma heads a busy week of deals that has seen J&J agree to pay $438m for Omrix and India’s Sun further its presence in the US narcotic APIs sector through the purchase of Chattem Chemicals.
Azopharma sets up UK lab
Contract development firm Azopharma has established a new laboratory facility in Welwyn Garden City, UK, which it hopes will facilitate its move into the European market.
Reps attack FDA; call for Obama to “clean house”
Members of the Committee on Energy and Commerce have said that recent actions by the FDA have been politically motivated and insufficient, although they did acknowledge the moves were necessary.
Sealing up the packaging market
Sepha has launched PakScan, its new leak testing machine that the company claims can quickly and non-destructively test for holes in sachets and sealed pouches.
Watson to buy Teva drugs for $36m
Watson Pharmaceuticals has paid Israeli generics firm Teva $36m (€27.6m) for 17 products that the latter firm is selling under the terms of its $7.5bn acquisition of Barr Pharmaceuticals.
Reaxa showcases Ni EnCat technology
Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.
ScinoPharm’s easy-filter irinotecan gets US patent
Taiwanese API maker ScinoPharm has been granted a US patent for new crystalline forms of irinotecan which are designed to allow for easier filtration during production processing.